ATE370243T1 - Screeningverfahren für einen auf die zellwand wirkenden arzneistoff - Google Patents

Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Info

Publication number
ATE370243T1
ATE370243T1 AT02775378T AT02775378T ATE370243T1 AT E370243 T1 ATE370243 T1 AT E370243T1 AT 02775378 T AT02775378 T AT 02775378T AT 02775378 T AT02775378 T AT 02775378T AT E370243 T1 ATE370243 T1 AT E370243T1
Authority
AT
Austria
Prior art keywords
cell wall
reporter protein
targeting site
medicinal
affecting
Prior art date
Application number
AT02775378T
Other languages
English (en)
Inventor
Akihiro Kitamura
Ryohei Nakajima
Original Assignee
Dalichi Sankyo Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalichi Sankyo Company Ltd filed Critical Dalichi Sankyo Company Ltd
Application granted granted Critical
Publication of ATE370243T1 publication Critical patent/ATE370243T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02775378T 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff ATE370243T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22

Publications (1)

Publication Number Publication Date
ATE370243T1 true ATE370243T1 (de) 2007-09-15

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02775378T ATE370243T1 (de) 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Country Status (9)

Country Link
US (1) US7459268B2 (de)
EP (1) EP1445327B1 (de)
JP (1) JP4204471B2 (de)
AT (1) ATE370243T1 (de)
CA (1) CA2464396A1 (de)
DE (1) DE60221883T2 (de)
ES (1) ES2294172T3 (de)
NO (1) NO20042089L (de)
WO (1) WO2003035898A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4204471B2 (ja) 2001-10-22 2009-01-07 第一三共株式会社 細胞壁作用性薬剤のスクリーニング方法
WO2007034986A1 (en) * 2005-09-22 2007-03-29 Suntory Limited Gene encoding cell wall mannoprotein and use thereof
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0673427T3 (da) 1992-07-08 2003-07-21 Unilever Nv Enzymatisk proces under anvendelse af enzymer immobiliseret på cellevæggen af en eukaryotisk mikrobiel celle ved fremstilling af et fusionsprotein
JPH0956384A (ja) 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (de) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
WO1999067419A1 (en) 1998-06-25 1999-12-29 The Collaborative Group, Ltd. β(1,6)-GLUCAN SYNTHESIS AND CELL WALL ASSEMBLY ASSAY
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
ES2312425T3 (es) 2000-05-01 2009-03-01 Daiichi Sankyo Company, Limited Procedimiento para cribar un medicamento que actua sobre la pared celular.
JP4204471B2 (ja) 2001-10-22 2009-01-07 第一三共株式会社 細胞壁作用性薬剤のスクリーニング方法

Also Published As

Publication number Publication date
EP1445327A4 (de) 2005-09-14
DE60221883D1 (de) 2007-09-27
NO20042089L (no) 2004-05-21
WO2003035898A1 (fr) 2003-05-01
JPWO2003035898A1 (ja) 2005-02-10
JP4204471B2 (ja) 2009-01-07
US20050069965A1 (en) 2005-03-31
DE60221883T2 (de) 2008-04-30
EP1445327B1 (de) 2007-08-15
EP1445327A1 (de) 2004-08-11
CA2464396A1 (en) 2003-05-01
US7459268B2 (en) 2008-12-02
ES2294172T3 (es) 2008-04-01

Similar Documents

Publication Publication Date Title
MXPA03000226A (es) Diagnosticos tempranos de enfermedades conformacionales.
BR0208597A (pt) Meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
BR0112385A (pt) Meio de coleta universal
ATE431427T1 (de) Verbessertes verfahren zum nachweis von atp
ATE412767T1 (de) Präbiotische effektanalyse
DE60042695D1 (de) Verfahren für den nachweis von erkrankungen
SE0004221D0 (sv) Metod och anordning för talanalys
FR2878109B1 (fr) Procede d'evaluation de la comptabilite entre des applications et des dispositifs de traitement
DK2204654T3 (da) Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekretioner
DK1399590T3 (da) Happier kortlægning
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
ATE395684T1 (de) Verfahren zur analyse der grundfrequenz, verfahren und vorrichtung zur sprachkonversion unter dessen verwendung
DE602004020668D1 (de) Verfahren und vorrichtungen zum dynamischen einfügen von vorabrufanweisungen auf der basis der müllsammelanalyse und des layouts von objekten
DE60221883D1 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
DE60334923D1 (de) Tät
ATE508201T1 (de) Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening
IL175692A0 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1661991A4 (de) Mit hepatozellulärem karzinom assoziiertes gen
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
WO2007074469A3 (en) Method and system for compiling a source code
DE60005832D1 (de) Verfahren zum nachweis von mastitis
DE60314258D1 (de) Gtp cyclohydrolase ii als ziel für fungizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties